BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5329635)

  • 1. Trifluperidol and trifluoperazine in acute schizophrenic patients.
    Sugerman AA; Williams BH
    J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients.
    Schiele BC; Janecek J; Zimmermann R
    Compr Psychiatry; 1969 Sep; 10(5):355-60. PubMed ID: 4389944
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of two butyrophenones with trifluoperazine.
    Marjerrison G; Hrychuk W; Varsanyi EI
    Can Psychiatr Assoc J; 1966 Feb; 11(1):26-30. PubMed ID: 5322990
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.
    Fish B; Campbell M; Shapiro T; Floyd A
    Curr Ther Res Clin Exp; 1969 Oct; 11(10):589-95. PubMed ID: 4981301
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia].
    Gauthier R; Hillel J; Bordeleau JM; Tétreault L
    Union Med Can; 1967 Aug; 96(8):936-43. PubMed ID: 5618135
    [No Abstract]   [Full Text] [Related]  

  • 7. Further observations on trifluperidol: a butyrophenone derivative.
    Gallant DM; Bishop MP; Nesselhof WM; Sprehe DJ
    Psychopharmacologia; 1965 Jan; 7(1):37-43. PubMed ID: 5318922
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of trifluperidol in chronic schizophrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4916807
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of trifluperidol in chronic schizaphrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4917285
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of the schizophrenic patient in a community psychiatric practice.
    Tobin JM
    Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
    [No Abstract]   [Full Text] [Related]  

  • 13. Trifluperidol and cholesterol in man.
    Clark ML; Braun GA; Hewson JR; Serafetinides EA; Colmore JP; Rahhal DK
    Clin Pharmacol Ther; 1968; 9(3):333-40. PubMed ID: 4870255
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis.
    Bankier RG
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):44-7. PubMed ID: 4566123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 16. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
    Bishop MP; Fulmer TE; Gallant DM
    Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777
    [No Abstract]   [Full Text] [Related]  

  • 17. [A year's use of R2498 with chronic ambulatory schizophrenic patients].
    Madalena JC
    Hospital (Rio J); 1965 Aug; 68(2):279-84. PubMed ID: 5295121
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical results with trifluoperidol in schizophrenic patients].
    Navarro MP; Assis LM; Martins C
    Rev Assoc Med Bras; 1966 Dec; 12(12):497-501. PubMed ID: 5241539
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 20. TRIFLUPERIDOL IN "PARANOID" AND "NON-PARANOID" SCHIZOPHRENICS.
    BISHOP MP; GALLANT DM
    Curr Ther Res Clin Exp; 1965 Feb; 7():96-101. PubMed ID: 14260091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.